Friday, February 06, 2009

What am I bid?

GlaxoSmithKline and Sanofi Aventis have emerged as bidders for Indian drug company Piramal, with the sale price perhaps going as high as $1.5 billion, a source familiar with the situation said on Friday.
Reuters

No comments: